Skip to content
10-Q

Quarterly Report

PRA Health Sciences, Inc.

0001613859-20-000032

← back to feed
Filed
Nov 5, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 30, 2020 64.15M sh
Shares Diluted Q3 2020 · Sep 30, 2020 64.87M sh
Shares Diluted Q3 2020 · Sep 30, 2020 64.56M sh
Shares Diluted Q3 2020 · Sep 30, 2019 66.21M sh
Shares Diluted Q3 2020 · Sep 30, 2019 66.61M sh
Stock Repurchased Q3 2020 · Sep 30, 2020 $0
Stock Repurchased Q3 2020 · Sep 30, 2019 $300M
Capex Q3 2020 · Sep 30, 2020 $54.02M
Capex Q3 2020 · Sep 30, 2019 $61.21M
Operating Cash Flow Q3 2020 · Sep 30, 2020 $267.1M
Operating Cash Flow Q3 2020 · Sep 30, 2019 $66M
Long Term Debt Q3 2020 · Sep 30, 2020 $1.26B
Long Term Debt Q3 2020 · Dec 31, 2019 $1.14B
Cash And Equivalents Q3 2020 · Sep 30, 2020 $336.23M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $236.23M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $181.77M
Cash And Equivalents Q3 2020 · Dec 31, 2018 $144.22M
Stockholders Equity Q3 2020 · Sep 30, 2020 $1.33B
Stockholders Equity Q3 2020 · Dec 31, 2019 $1.09B
Current Liabilities Q3 2020 · Sep 30, 2020 $999.74M
Current Liabilities Q3 2020 · Dec 31, 2019 $1.02B
Total Liabilities Q3 2020 · Sep 30, 2020 $2.51B
Total Liabilities Q3 2020 · Dec 31, 2019 $2.45B
Current Assets Q3 2020 · Sep 30, 2020 $1.13B
Current Assets Q3 2020 · Dec 31, 2019 $985.57M
Total Assets Q3 2020 · Sep 30, 2020 $3.84B
Total Assets Q3 2020 · Dec 31, 2019 $3.54B
Eps Diluted Q3 2020 · Sep 30, 2020 $1.41
Eps Diluted Q3 2020 · Sep 30, 2020 $2.26
Eps Diluted Q3 2020 · Sep 30, 2019 $1.25
Eps Diluted Q3 2020 · Sep 30, 2019 $2.53
Eps Basic Q3 2020 · Sep 30, 2020 $1.44
Eps Basic Q3 2020 · Sep 30, 2020 $2.31
Eps Basic Q3 2020 · Sep 30, 2019 $1.28
Eps Basic Q3 2020 · Sep 30, 2019 $2.58
Sga Expense Q3 2020 · Sep 30, 2020 $115.41M
Sga Expense Q3 2020 · Sep 30, 2020 $332.35M
Sga Expense Q3 2020 · Sep 30, 2019 $95.54M
Sga Expense Q3 2020 · Sep 30, 2019 $291.44M
Net Income Q3 2020 · Sep 30, 2020 $91.25M
Net Income Q3 2020 · Sep 30, 2020 $145.79M
Net Income Q3 2020 · Sep 30, 2019 $83.01M
Net Income Q3 2020 · Sep 30, 2019 $168.22M
Operating Income Q3 2020 · Sep 30, 2020 $124.16M
Operating Income Q3 2020 · Sep 30, 2020 $230.97M
Operating Income Q3 2020 · Sep 30, 2019 $95.79M
Operating Income Q3 2020 · Sep 30, 2019 $262.53M
Revenue Q3 2020 · Sep 30, 2020 $796.31M
Revenue Q3 2020 · Sep 30, 2020 $2.31B
Revenue Q3 2020 · Sep 30, 2019 $780.69M
Revenue Q3 2020 · Sep 30, 2019 $2.27B